| Target Price | $20.40 |
| Price | $2.04 |
| Potential |
900.00%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target BIO-key International, Inc. 2027 .
The average BIO-key International, Inc. target price is $20.40.
This is
900.00%
register free of charge
$21.00
929.41%
register free of charge
$20.20
890.20%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend BIO-key International, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BIO-key International, Inc. stock has an average upside potential 2027 of
900.00%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 6.93 | 7.45 |
| 10.58% | 7.45% | |
| Net Margin | -62.05% | -73.97% |
| 43.56% | 19.21% |
3 Analysts have issued a sales forecast BIO-key International, Inc. 2025 . The average BIO-key International, Inc. sales estimate is
This results in the following potential growth metrics:
3 BIO-key International, Inc. Analysts have issued a net profit forecast 2025. The average BIO-key International, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -20.88 | -5.10 |
| 86.27% | 75.57% | |
| P/E | negative | |
| EV/Sales | 0.27 |
3 Analysts have issued a BIO-key International, Inc. forecast for earnings per share. The average BIO-key International, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BIO-key International, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


